In March 2014 a new spin-off company of Masaryk University was incorporated into the Companies’ Register – the Institute of Biostatistics and Analyses, Ltd. (IBA, Ltd.) Why was it established and what goals does it aim to achieve?
The spin-off was conceived by the team of the Institute of Biostatistics and Analyses of Masaryk University (IBA MU) – an academic institution specialising in research and training in the field of biostatistics, evaluation of medical technologies and applied medical informatics. This institute stands behind the field of Mathematical Biology at the Faculty of Science; it also participates in a number of projects and post-gradual education at the Faculty of Medicine. Besides these academic activities, the cost centre of IBA MU manages a lot of research projects which often concern the commercial sector. These include e.g. clinical trials, development and implementation of hospital data collection software, management of clinical research projects and related services.
The Institute of Biostatistics and Analyses is an investigator of the project “Extending services portfolio of an information system for the data management in clinical research”. The project is supported by the OP EIC from the European Union funds.
Main objective of the project is the development of a platform for composition of information systems focused on data management and data mining in the field of pharmaceutical industry and life sciences. Offer of digital services based on a developed and validated information system will make reliable analytical models accessible to the companies for their decision-making and precise information sources for regulatory bodies. The project steps out of a laboratory environment of clinical trials and focuses on the evidence supported by real-world data.
